Health Psychology Research / HPR / Volume 2 / Issue 1 / DOI: 10.4081/​hpr.2014.1389
GENERAL

 Improving maintenance  medication adherence in adult  inflammatory bowel disease  patients: a pilot study

Michelle L. Matteson-Kome1* Jessica Winn2 Matthew L. Bechtold1 Jack D. Bragg1 Cynthia L. Russell3
Show Less
1 Division of Gastroenterology and Hepatology, Sinclair School of Nursing, University of Missouri, Columbia, MO
2 Department of Internal Medicine, University of Missouri, Columbia, MO
3 Department of Internal Medicine, University of Missouri, Columbia, MO
Submitted: 18 February 2013 | Revised: 11 March 2013 | Accepted: 11 March 2013 | Published: 13 January 2014
© 2014 by the Author(s). Licensee Health Psychology Research, USA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Medication nonadherence in inflammatory bowel disease (IBD) may lead to suboptimal control of the disease, decreased quality of life, and poor outcomes. This pilot study evaluated the feasibility, intervention mechanism, and potential effectiveness of a three-month con tinuous self-improvement (CSI) intervention to enhance medication adherence (MA) in adult nonadherent IBD patients. Adult IBD patients taking a daily or twice-daily dosed maintenance medication were screened elec tronically for two months to determine base line MA levels. Nonadherent IBD participants were randomized to the CSI or the attention control (AC) intervention and monitored for three months. The CSI intervention consisted of a data evaluation and system refinement process in which system changes were identi fied and implemented. The AC group was given educational information regarding IBD dis ease process, extra-intestinal manifestations of IBD, and medical therapy. Demographic sta tistics, change scores for within and between group differences, and effect size estimates were calculated. Nine nonadherent partici pants (medication adherence score <0.85) were eligible for randomization. The interven tion was found feasible and acceptable. Although no statistically significant improve ment in MA was found (P=0.14), adherence improved in 3 of 4 of the CSI group and 1 of 2 in the attention control group. The effect size calculation of 1.9 will determine the sample size for future study. The results of this pilot study showed the intervention was feasible and had a positive effect on MA change score and adherence levels. A larger fully powered study is needed to test of the effectiveness of this innovative intervention.

Keywords
adherence
inflammatory bowel dis ease
intervention
References

1. Sabaté, E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003.
2. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998;36:1138-61.
3. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003;60:657-65.
4. McDonald HP, Garg A, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868-79.
5. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007;167:540-50.
6. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17.
7. Lichtenstein GR. Current research in Crohn's disease and ulcerative colitis: highlights from the 2010 ACG Meeting. Gastroenterol Hepatol 2010;6:3-14.
8. Hanauer SB. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis. Aliment Pharmacol Ther 2006;24:37-40.
9. Jackson CA, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol 2010:105:525-39.
10. Hawthorne AB, Rubin G, Ghosh S. Review article: medication non-adherence in ulcerative colitis--strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther 2008;27:1157-66.
11. Matteson, M.L., Russell, C.L. Systematic review of continuous self-improvement interventions. 2011. [In press].
12. Russell CL. A clinical nurse specialist-led intervention to enhance medication adherence using the plan-do-check-act cycle for continuous self-improvement. Clin Nurse Spec 2010;24:69-75.
13. Gustafson DH, Cats-Baril WL, Alemi F. Systems to support health policy analysis: theory, models, and uses. Ann Arbor: Health Administration Press; 1992.
14. Alemi F, Neuhauser D, Ardito S, et al. Continuous self-improvement: systems thinking in a personal context. Jt Comm J Qual Improv 2000;26:74-86.
15. Alemi F, Neuhauser D, eds. A thinking person's weight loss and exercise program. Fairfax: George Mason University; 2006.
16. Russell CL, Conn V, Ashbaugh C, et al. Intra-subject medication adherence patterns. Clin Nurs Res 2007;16:153.
17. Denhaerynck K, Schaefer-Keller P, Young J, et al. Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol 2008;8:5.
18. De Geest S, Vanhaecke J. Methodological issues in transplant compliance research. Transplant Proc 1999;31:81S-3.
19. Reikert KA. Integrating regimen adherence assessment into clinical practice. In: O'Donohue WT, Levensky ER (Ed.). Promoting treatment adherence: a practical handbook for health care providers. Thousand Oaks: Sage Publishers; 2006.
20. De Geest S, Schafer-Keller P, Denhaerynck K, et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant 2006;20:359-68.
21. Kruse W, Weber E. Dynamics of drug regimen compliance-its assessment by microprocessor-based monitoring. Eur J Clin Pharm 1990;38:561-5.
22. Russell CL, Conn VS, Ashbaugh C, et al. Medication adherence patterns in adult renal transplant recipients. Res Nurs Health 2006;29:521-32.
23. Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: a randomized controlled trial. Can J Gastroenterol 2005;19:235-44.
24. Moss AC, Chaudhary N, Tukey M, et al. Impact of a patient-support program on mesalamine adherence in patients with ulcerative colitis--a prospective study. J Crohns Colitis 2010;4:171-5.
25. Cook PF, Emiliozzi S, El-Hajj D, McCabe MM. Telephone nurse counseling for medication adherence in ulcerative colitis: a preliminary study. Patient Educ Couns 2010;81:182-6.
26. Moshkovska T, Stone M, Baker R., et al. Qualitative investigation of patient adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis. Inflamm Bowel Dis 2008;14:763-8.
27. Keefer L, Doerfler B, Artz C. Optimizing management of Crohn's disease within a project management framework: results of a pilot study. Inflamm Bowel Dis 2012;18:254-60.
28. Conn VS, Hafdahl AR, Cooper PS, et al. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist 2009;49:447-62.
29. Polit D, Beck, C. nursing research: principles and methods. 9th Ed. Philadelphia: Lippincott, Williams & Wilkins; 2012.
30. Russell CR, Ruppar TR, Matteson ML. Improving medication adherence: moving from intention and motivation to a personal systems approach. Nurs Clin North Am September 2011;46:271-81.

Conflict of interest
The authors declare no potential conflict of interests.
Share
Back to top
Health Psychology Research, Electronic ISSN: 2420-8124 Published by Health Psychology Research